SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘8-K’ for 11/1/20

On:  Wednesday, 11/4/20, at 6:48pm ET   ·   As of:  11/5/20   ·   For:  11/1/20   ·   Accession #:  1213900-20-35105   ·   File #:  1-35527

Previous ‘8-K’:  ‘8-K’ on / for 10/29/20   ·   Next:  ‘8-K’ on 11/13/20 for 10/28/20   ·   Latest:  ‘8-K’ on 2/26/24 for 2/21/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/05/20  Emmaus Life Sciences, Inc.        8-K:4,9    11/01/20    2:26K                                    EdgarAgents LLC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     17K 
 2: EX-16.1     Letter Dated November 4, 2020 From Squar Milner,    HTML      5K 
                LLP to the Securities and Exchange Commission                    




        
Filing Submission 0001213900-20-035105 – SGML Text

Original SGML Text submitted by:  EdgarAgents LLC/FA  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 26K                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20201105-070249	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20201105-060231	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20201104-184859	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001213900-20-035105
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		2
<PERIOD>			20201101
<ITEMS>				4.01
<ITEMS>				9.01
<FILING-DATE>			20201105
<DATE-OF-FILING-DATE-CHANGE>	20201104
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Emmaus Life Sciences, Inc.
<CIK>				0000822370
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			870419387  87-0419387
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-35527
<FILM-NUMBER>			201288087
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			21250 HAWTHORNE BOULEVARD, SUITE 800
<CITY>				TORRANCE
<STATE>				CA
<ZIP>				90503
<PHONE>				310-214-0065
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			21250 HAWTHORNE BOULEVARD, SUITE 800
<CITY>				TORRANCE
<STATE>				CA
<ZIP>				90503
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		MYnd Analytics, Inc.
<DATE-CHANGED>			20151211
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		CNS RESPONSE, INC.
<DATE-CHANGED>			20070313
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		STRATIVATION, INC.
<DATE-CHANGED>			20051115
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	ea129188-8k_emmauslife.htm
<DESCRIPTION>	CURRENT REPORT
<TEXT>
<HTML>
       Show <HTML>: 324 lines (widest: 473 characters) - 23K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-16.1
<SEQUENCE>	2
<FILENAME>	ea129188ex16-1_emmauslife.htm
<DESCRIPTION>	LETTER DATED NOVEMBER 4, 2020 FROM SQUAR MILNER, LLP TO THE
		SECURITIES AND EXCHANGE COMMISSION
<TEXT>
<HTML>
       Show <HTML>: 54 lines (widest: 128 characters) - 3K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0001213900-20-035105   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 10:47:39.2pm ET